|30th October 2020||Patrick Mercer||71||Payment by withholding||$1.78||$126.38|
|30th September 2020||Patrick Mercer||72||Payment by withholding||$1.96||$141.12|
|3rd September 2020||Patrick Mercer||15,000||Grant/award etc.||$0.00|
|3rd September 2020||David Bruce||28,000||Grant/award etc.||$0.00|
|30th August 2020||Patrick Mercer||71||Payment by withholding||$2.12||$150.52|
|14th August 2020||Ken Ludlum||6,470||Open or private sale||$20.42||$132,117.40|
|14th August 2020||Ken Ludlum||13,530||Open or private sale||$20.05||$271,276.50|
|30th July 2020||Patrick Mercer||71||Payment by withholding||$2.11||$149.81|
|16th July 2020||Maria Sainz||4,122||Grant/award etc.||$0.00|
|1st July 2020||David Bruce||5,378||Payment by withholding||$2.12||$11,401.36|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989.